Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALO-02 Safety Study in Chronic Noncancer Pain
NCT01428583Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone, naltrexone in chronic pain, sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
oxycodonenaltrexone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT01428583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428583.